BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 26036779)

  • 21. Detection of breast cancer microcalcification using (99m)Tc-MDP SPECT or Osteosense 750EX FMT imaging.
    Felix DD; Gore JC; Yankeelov TE; Peterson TE; Barnes S; Whisenant J; Weis J; Shoukouhi S; Virostko J; Nickels M; McIntyre JO; Sanders M; Abramson V; Tantawy MN
    Nucl Med Biol; 2015 Mar; 42(3):269-73. PubMed ID: 25533764
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Mandiwana V; Kalombo L; Grobler A; Zeevaart JR
    Appl Radiat Isot; 2018 Nov; 141():51-56. PubMed ID: 30170270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic hepatic uptake of (99m)Tc methylene diphosphonate: a case report.
    MacDonald J
    J Nucl Med Technol; 2001 Mar; 29(1):32-6. PubMed ID: 11283215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of quantitative uptake of (99m)Tc-MDP and (99m)Tc-HMPAO white blood cells in detecting osteomyelitis in violated peripheral bones.
    Ballani NS; Al-Huda FA; Khan HA; Al-Mohannadi S; Mahmood H; Al-Enezi F
    J Nucl Med Technol; 2007 Jun; 35(2):91-5. PubMed ID: 17496004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
    J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
    Ergün EL; Kiratli PO; Günay EC; Erbaş B
    Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of low grade exercise on skeletal scintigraphy using Tc-99m methylene diphosphonate.
    Amin A; El-Kareem MA; Yahia AB
    Nucl Med Rev Cent East Eur; 2015; 18(2):61-4. PubMed ID: 26315864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative studies of bone in postmenopausal women using (18)F-fluoride and (99m)Tc-methylene diphosphonate.
    Blake GM; Park-Holohan SJ; Fogelman I
    J Nucl Med; 2002 Mar; 43(3):338-45. PubMed ID: 11884493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tracheal uptake on Tc-99m MDP bone scintigraphy can be a potential source of false-positive results in a prostate cancer patient.
    Sood A; Sethi S; Kumar R
    Clin Nucl Med; 2010 Jun; 35(6):454-5. PubMed ID: 20479601
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetic and imaging evaluation of (99m)Tc-HBIDP as a potential bone imaging agent.
    Qiu L; Lin J; Nan B; Lv G; Cheng W
    Pak J Pharm Sci; 2015 May; 28(3):815-8. PubMed ID: 26004712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disassociation of splenic accumulation of Tc-99m MDP and radiocolloid.
    Spencer RP; Sziklas JJ; Zubi SM
    Clin Nucl Med; 1991 Oct; 16(10):747-9. PubMed ID: 1742928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic uptake of Tc-99m MDP on bone scintigraphy from intravenous iron therapy (Blutal).
    Park CH; Kim HS; Shin HY; Kim HC
    Clin Nucl Med; 1997 Nov; 22(11):762-4. PubMed ID: 9363385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnostic value of (99m)Tc-IgG scintigraphy in the diabetic foot and comparison with (99m)Tc-MDP scintigraphy.
    Asli IN; Javadi H; Seddigh H; Mogharrabi M; Hooman A; Ansari M; Jalallat S; Assadi M
    J Nucl Med Technol; 2011 Sep; 39(3):226-30. PubMed ID: 21795373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Splenic uptake of Tc-99m MDP in a patient with hemochromatosis.
    Sabnis SS; Blend MJ
    Clin Nucl Med; 1999 Aug; 24(8):622-3. PubMed ID: 10439195
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
    Abbasi IA
    Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of ultrafiltration as a method of measuring free 99mTc-MDP.
    Moore AE; Hain SF; Blake GM; Fogelman I
    J Nucl Med; 2003 Jun; 44(6):891-7. PubMed ID: 12791815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
    Degrossi OJ; Oliveri P; García del Río H; Labriola R; Artagaveytía D; Degrossi EB
    J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffuse hepatic uptake of (99m)Tc methylene diphosphonate on bone scintigraphy in a case of hypercalcemia and diffuse large B cell lymphoma.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Hell J Nucl Med; 2013; 16(1):66-7. PubMed ID: 23789120
    [No Abstract]   [Full Text] [Related]  

  • 39. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication.
    Van Duzee BF; Schaefer JA; Ball JD; Chilton HM; Cowan RJ; Kuni C; Trow R; Watson NE
    J Nucl Med; 1984 Feb; 25(2):166-9. PubMed ID: 6233404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of tumor absorbed dose by Tc-99m-MDP scintigraphy prior to treatment with Sr-89.
    Manetou A; Limourls GS
    Anticancer Res; 1997; 17(3B):1845-7. PubMed ID: 9179243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.